Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

599
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
599
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

828
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
828
Functional Classification of Joints01:09

Functional Classification of Joints

7.2K
Functional Classification of Joints
The functional classification of joints is determined by the amount of mobility between the adjacent bones. Joints are functionally classified as a synarthrosis or immobile joint, an amphiarthrosis or slightly moveable joint, or as a diarthrosis, a freely moveable joint. Fibrous and cartilaginous joints can be functionally classified as either synarthroses  or amphiarthroses, whereas all synovial joints are classified as diarthroses.
Synarthrosis
An...
7.2K
Structural Joints: Cartilaginous Joints01:17

Structural Joints: Cartilaginous Joints

4.3K
As the name indicates, at a cartilaginous joint, the adjacent bones are united by cartilage, a tough but flexible type of connective tissue. Unlike synovial joints, these types of joints lack a joint cavity and involve bones joined together by either hyaline cartilage or fibrocartilage.
There are two types of cartilaginous joints:
Synchondrosis
A synchondrosis ("joined by cartilage") is a cartilaginous joint where bones are connected by hyaline cartilage. Synchondrosis may be temporary...
4.3K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

715
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
715
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.8K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Development of quality standards for patients with rheumatoid arthritis for use in Germany].

Zeitschrift fur Rheumatologie·2021
Same author

[Development of quality standards for patients with axial spondyloarthritis for use in Germany].

Zeitschrift fur Rheumatologie·2021
Same author

[Quality in acute inpatient rheumatology 2021 : Current aspects of the KOBRA quality label of the Association of Rheumatological Acute Care Clinics].

Zeitschrift fur Rheumatologie·2021
Same author

Mission statement from rheumatologists in the German Society of Rheumatology (DGRh e. V.) : We live rheumatology.

Zeitschrift fur Rheumatologie·2020
Same author

[Mission statement from rheumatologists in the German Society of Rheumatology (DGRh e. V.) : We live rheumatology. German version].

Zeitschrift fur Rheumatologie·2020
Same author

[Long version on the S3 guidelines for axial spondyloarthritis including Bechterew's disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations].

Zeitschrift fur Rheumatologie·2019
Same journal

[Prevention strategies in rheumatoid arthritis : From primary prevention to targeted drug interception].

Zeitschrift fur Rheumatologie·2026
Same journal

Methodological concerns and data discrepancies in the indirect treatment comparison of belimumab and anifrolumab.

Zeitschrift fur Rheumatologie·2026
Same journal

Evaluating the comparative efficacy of belimumab vs. anifrolumab in systemic lupus erythematosus: a response.

Zeitschrift fur Rheumatologie·2026
Same journal

[Update: DMARDs for MGUS].

Zeitschrift fur Rheumatologie·2026
Same journal

[A potpourri of diagnoses-Unusual manifestations of a chronic inflammatory bowel disease : Case report].

Zeitschrift fur Rheumatologie·2026
Same journal

[Not measurable but immeasurably important : Fever-The leading symptom of ancient medical theory].

Zeitschrift fur Rheumatologie·2026
See all related articles

Related Experiment Video

Updated: Feb 20, 2026

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
04:47

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice

Published on: October 27, 2023

1.8K

[Spondyloarthritides].

M Rudwaleit1

  • 1Klinik für Innere Medizin und Rheumatologie, Klinikum Bielefeld Rosenhöhe, An der Rosenhöhe 27, 33647, Bielefeld, Deutschland. martin.rudwaleit@klinikumbielefeld.de.

Zeitschrift Fur Rheumatologie
|October 19, 2017
PubMed
Summary
This summary is machine-generated.

Spondyloarthritides (SpA) are inflammatory diseases impacting the skeleton and joints. Key factors include genetics like HLA-B27 and the interleukin 23/17 pathway, guiding new treatments for inflammatory back pain.

Keywords:
Anti-inflammatory agents, non-steroidalArthritis, psoriaticSacroiliitisSpondylitis, ankylosingTumor necrosis factor alpha, inhibitors

More Related Videos

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis
06:23

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis

Published on: May 23, 2021

5.5K
Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
09:18

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue

Published on: February 24, 2023

10.5K

Related Experiment Videos

Last Updated: Feb 20, 2026

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
04:47

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice

Published on: October 27, 2023

1.8K
Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis
06:23

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis

Published on: May 23, 2021

5.5K
Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
09:18

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue

Published on: February 24, 2023

10.5K

Area of Science:

  • Rheumatology
  • Immunology
  • Genetics

Background:

  • Spondyloarthritides (SpA) encompass inflammatory rheumatic conditions affecting the axial skeleton, peripheral joints, entheses, and extraskeletal sites.
  • Current classification distinguishes between predominant axial SpA and predominant peripheral SpA, with axial SpA further categorized into radiographic and nonradiographic forms.

Purpose of the Study:

  • To summarize the current understanding of Spondyloarthritides (SpA), including classification, key genetic and molecular factors, clinical presentation, diagnosis, and therapeutic strategies.
  • To highlight the significance of the interleukin 23/17 pathway as a therapeutic target.

Main Methods:

  • Literature review and synthesis of current knowledge on SpA.
  • Analysis of diagnostic criteria, including the role of HLA-B27 and imaging findings like sacroiliitis.
  • Overview of therapeutic approaches, differentiating between axial and peripheral manifestations.

Main Results:

  • Genetic factors, particularly HLA-B27, play a crucial role in SpA.
  • The interleukin 23/17 pathway is implicated in SpA pathogenesis, suggesting novel therapeutic targets.
  • Inflammatory back pain is a characteristic leading symptom of axial SpA.
  • Diagnosis relies on clinical symptoms, genetic markers (HLA-B27), and imaging (sacroiliitis).

Conclusions:

  • Therapeutic strategies for SpA include physiotherapy, NSAIDs as first-line treatment, and biologics as second-line therapy for axial SpA.
  • Conventional disease-modifying antirheumatic drugs demonstrate efficacy primarily in peripheral arthritis.
  • Understanding the underlying mechanisms, such as the IL-23/17 pathway, is vital for developing targeted treatments for SpA.